https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2001-03-01 / J. Gastroenterol. Hepatol. 2001 Mar;16(3):309-16
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2001-03-01 / J. Gastroenterol. Hepatol. 2001 Mar;16(3):309-162001-03-01 00:00:002019-02-15 08:37:58Generation of hepatitis C virus-specific cytotoxic T lymphocytes from healthy individuals with peptide-pulsed dendritic cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2001-03-01 / Nat. Med. 2001 Mar;7(3):297-303
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2001-03-01 / Nat. Med. 2001 Mar;7(3):297-3032001-03-01 00:00:002001-03-01 00:00:00Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2001-02-01 / Cancer Res. 2001 Feb;61(3):842-7
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2001-02-01 / Cancer Res. 2001 Feb;61(3):842-72001-02-01 00:00:002019-02-15 08:47:03Vaccination of malignant glioma patients with peptide-pulsed dendritic cells elicits systemic cytotoxicity and intracranial T-cell infiltration
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2001-02-01 / Onkologie 2001 Feb;24(1):55-8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2001-02-01 / Onkologie 2001 Feb;24(1):55-82001-02-01 00:00:002019-02-15 09:17:56Posttreatment histology and microcirculation status of osteogenic sarcoma after a neoadjuvant chemo- and radiotherapy in combination with local electromagnetic hyperthermia
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2001-01-01 / J. Cancer Res. Clin. Oncol. 2001;127(3):203-6
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2001-01-01 / J. Cancer Res. Clin. Oncol. 2001;127(3):203-62001-01-01 00:00:002019-02-15 08:53:39In vitro induction of a bladder cancer-specific T-cell response by mRNA-transfected dendritic cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2001-01-01 / Clin. Cancer Res. 2001 Jan;7(1):23-31
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2001-01-01 / Clin. Cancer Res. 2001 Jan;7(1):23-312001-01-01 00:00:002019-02-15 08:53:40Immunotherapy of bladder cancer using autologous dendritic cells pulsed with human lymphocyte antigen-A24-specific MAGE-3 peptide
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2001-01-01 / Cancer Invest. 2001;19(8):791-8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2001-01-01 / Cancer Invest. 2001;19(8):791-82001-01-01 00:00:002001-01-01 00:00:00Effect of hyperthermia on AKR lymphoma variants differing in degree of malignancy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2001-01-01 / Intervirology 2001;44(4):199-208
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2001-01-01 / Intervirology 2001;44(4):199-2082001-01-01 00:00:002019-02-15 08:37:58Dendritic cells and chronic hepatitis virus carriers
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2001-01-01 / Exp. Hematol. 2001 Jan;29(1):85-92
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2001-01-01 / Exp. Hematol. 2001 Jan;29(1):85-922001-01-01 00:00:002019-02-15 08:51:14Dendritic cells derived from multiple myeloma patients efficiently internalize different classes of myeloma protein
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2000-12-15 / Neurosurg Focus 2000 Dec;9(6):e8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2000-12-15 / Neurosurg Focus 2000 Dec;9(6):e82000-12-15 00:00:002019-02-15 08:46:54Treatment of a patient by vaccination with autologous dendritic cells pulsed with allogeneic major histocompatibility complex class I-matched tumor peptides. Case Report
